Background: An estimated 70% of cervical cancers worldwide are attributable to persistent
infection with human papillomaviruses (HPV) 16 and 18. Vaccination against HPV 16/18 has …

Objectives: Cervical cancer (CC) had the second highest incidence of female cancers in
Malaysia in 2003-2006. Prevention is possible by both Pap smear screening and HPV …

Introduction The clinical and economic impact of cervical cancer consistently become a
serious burden for all countries, including Indonesia. The implementation of HPV …

Introduction: Cervical cancers (CC) demonstrate the second highest incidence of female
cancers in Malaysia. The costs of chronic management have a high impact on nation's …

Background Human papillomavirus (HPV) vaccines represent an important strategic
opportunity to prevent cervical cancer in low‐middle income countries, such as India. The …

Background The human papillomavirus (HPV) vaccine was introduced into Thailand's
national immunization program in 2017 for 11–12 year old school girls. The objectives of this …

Background Current prophylactic vaccines against human papillomavirus (HPV) target two
of the most oncogenic types, HPV-16 and-18, which contribute to roughly 70% of cervical …

Objective: National cervical cancer prevention program has been initiated in Indonesia since
April 2015 and the ministry of health has started efforts to integrate the HPV Vaccine in the …

Background Human papillomavirus (HPV) vaccines are widely available and there have
been studies exploring their potential clinical impact and cost-effectiveness. However, few …

Cervical cancer is a leading cause of cancer death among women in low-income countries,
with∼ 25% of cases worldwide occurring in India. We estimated the potential health and …